Michael Gelband ExodusPoint Capital Management
Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$74.9M |
| 2 |
Aramark
ARMK
|
+$58.3M |
| 3 |
Colgate-Palmolive
CL
|
+$21.7M |
| 4 |
NextEra Energy
NEE
|
+$16.9M |
| 5 |
Coca-Cola
KO
|
+$16.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AABA
Altaba Inc
AABA
|
+$114M |
| 2 |
iQIYI
IQ
|
+$19.6M |
| 3 |
AerCap
AER
|
+$18.3M |
| 4 |
Public Service Enterprise Group
PEG
|
+$12.5M |
| 5 |
Howard Hughes
HHH
|
+$12.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Utilities | 13.39% |
| 2 | Technology | 9.99% |
| 3 | Consumer Discretionary | 6.99% |
| 4 | Industrials | 6.47% |
| 5 | Consumer Staples | 6.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Tractor Supply
TSCO
$18.7B
| $522K | 0.02% |
+24,000
| New | +$496K |
|
452
Linde
LIN
$226B
| $521K | 0.02% |
+2,593
| New | +$485K |
|
|
DOVA
453
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
| $520K | 0.02% |
+36,900
| New | +$351K |
|
454
Crown Holdings
CCK
$13B
| $519K | 0.02% |
+8,500
| New | +$496K |
|
455
Universal Display
OLED
$3.89B
| $519K | 0.02% |
2,758
-2,738
| -50% | -$455K |
|
456
Bank OZK
OZK
$5.38B
| $518K | 0.02% |
+17,203
| New | +$533K |
|
457
Factset
FDS
$10.9B
| $516K | 0.02% |
+1,800
| New | +$498K |
|
|
SEMG
458
DELISTED
SEMGROUP CORPORATION
SEMG
| $516K | 0.02% |
+43,000
| New | +$570K |
|
|
AERI
459
DELISTED
Aerie Pharmaceuticals
AERI
| $515K | 0.02% |
+17,421
| New | +$671K |
|
460
PayPal
PYPL
$52.8B
| $513K | 0.02% |
4,479
+1,934
| +76% | +$214K |
|
|
PVTL
461
DELISTED
Pivotal Software, Inc.
PVTL
| $510K | 0.02% |
+48,289
| New | +$857K |
|
|
CBB
462
DELISTED
Cincinnati Bell Inc.
CBB
| $510K | 0.02% |
103,119
+5,541
| +6% | +$42.5K |
|
463
CF Industries
CF
$19.6B
| $509K | 0.02% |
+10,906
| New | +$473K |
|
464
Lockheed Martin
LMT
$130B
| $509K | 0.02% |
+1,400
| New | +$468K |
|
|
BEST
465
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
| $507K | 0.02% |
4,605
-7,519
| -62% | -$779K |
|
466
United Therapeutics
UTHR
$22B
| $506K | 0.02% |
+6,482
| New | +$606K |
|
467
Fulton Financial
FULT
$4.5B
| $505K | 0.02% |
+30,867
| New | +$508K |
|
468
Marvell Technology
MRVL
$206B
| $501K | 0.02% |
+21,000
| New | +$491K |
|
469
The RealReal
REAL
$1.37B
| $501K | 0.02% |
+17,325
| New | +$501K |
|
470
Hasbro
HAS
$13.5B
| $499K | 0.02% |
+4,725
| New | +$466K |
|
471
Strategic Education
STRA
$1.87B
| $499K | 0.02% |
+2,806
| New | +$460K |
|
472
Cummins
CMI
$78.7B
| $497K | 0.02% |
+2,903
| New | +$475K |
|
473
CSX Corp
CSX
$95.3B
| $497K | 0.02% |
19,254
+10,443
| +119% | +$269K |
|
|
BMCH
474
DELISTED
BMC Stock Holdings, Inc
BMCH
| $497K | 0.02% |
+23,459
| New | +$487K |
|
475
W.R. Berkley
WRB
$25.9B
| $496K | 0.02% |
+16,938
| New | +$464K |
|
Similar funds
Michael Gelband's Q2 2019 Portfolio in Review
As of Q2 2019, Michael Gelband held 1,466 positions worth $2.51B, up 87% from $1.34B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Michael Gelband deployed $1.14B of net new capital in Q2 2019, opening 813 new positions and adding to 130 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 260,259 shares worth $76.3M.
By sector, the portfolio is most concentrated in Utilities at 13% of assets, down from 22% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Altaba Inc, an estimated $114M trimmed.
- Michael Gelband's largest Q2 2019 buy was State Street SPDR S&P 500 ETF Trust: 260,259 shares worth $76.3M.
- Michael Gelband added most to Aramark in Q2 2019, an estimated $58.3M increase.
- Michael Gelband's biggest Q2 2019 reduction was Altaba Inc, cutting an estimated $114M.
- Michael Gelband fully exited AerCap in Q2 2019, selling an estimated $18.3M.
- Michael Gelband's ten largest holdings make up 46% of its $2.51B portfolio in Q2 2019.
- Michael Gelband opened 813 new positions and closed 402 in Q2 2019.
- Michael Gelband's portfolio value rose 87% quarter-over-quarter to $2.51B.
Based on ExodusPoint Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.